Randomized Trial: Effect of Dasatinib vs. Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
19 Jan, 2020 | 20:38h | UTCEffect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Commentary: Dasatinib Superior to Imatinib in Pediatric ALL – MedPage Today (free)